Pro Wrestler “Hannibal” Is Cured of Hep C

This is according to the large randomized controlled START trial.

Weight-based Harvoni treatment cured almost almost all of a small group of very young people.

One researcher argues that the pharmaceutical industry ought to pay greater heed to such risks during drug development.

Among those who switched their hep B treatment, Vemlidy may also be tied to a higher chance of ALT liver enzyme normalization.

Caring for someone with cirrhosis is hard work and much harder when there is hepatic encephalopathy.

A recent analysis of two studies of AbbVie’s hepatitis C regimen showed good results in this population.

In a recent study of Gilead’s Epclusa (sofosbuvir/velpatasvir), 92 percent of participants were on dialysis and 29 percent had cirrhosis.

This is according to the largest-ever analysis of the treatment cascade among people tested for hep C.

Whether such recurrence is less likely after interferon treatment remains the source of some controversy in the hep C research community.